Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.

Saved in:
Bibliographic Details
Title: Identifying treatment options for BRAFV600 wild-type metastatic melanoma: A SU2C/MRA genomics-enabled clinical trial.
Authors: LoRusso PM; Yale Cancer Center, Yale University, New Haven, CT, United States of America., Sekulic A; Mayo Clinic, Scottsdale, AZ, United States of America.; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Sosman JA; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Evanston, IL, United States of America., Liang WS; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Carpten J; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America., Craig DW; Keck School of Medicine, University of Southern California, Los Angeles, CA, United States of America., Solit DB; Memorial Sloan Kettering Cancer Center, New York, NY, United States of America., Bryce AH; Mayo Clinic, Scottsdale, AZ, United States of America., Kiefer JA; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Aldrich J; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Nasser S; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Halperin R; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Byron SA; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Pilat MJ; Eugene Applebaum College of Pharmacy and Health Sciences, Wayne State University, Detroit, MI, United States of America., Boerner SA; Yale Cancer Center, Yale University, New Haven, CT, United States of America., Durecki D; Yale Cancer Center, Yale University, New Haven, CT, United States of America., Hendricks WPD; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Enriquez D; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Izatt T; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Keats J; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Legendre C; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Markovic SN; Mayo Clinic, Rochester, MN, United States of America., Weise A; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States of America., Naveed F; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Schmidt J; Mayo Clinic, Scottsdale, AZ, United States of America., Basu GD; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Sekar S; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Adkins J; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Tassone E; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Sivaprakasam K; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Zismann V; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Calvert VS; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, United States of America., Petricoin EF; Center for Applied Proteomics and Molecular Medicine, George Mason University, Manassas, VA, United States of America., Fecher LA; University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, United States of America., Lao C; University of Michigan Comprehensive Cancer Center, University of Michigan, Ann Arbor, MI, United States of America., Eder JP; Yale Cancer Center, Yale University, New Haven, CT, United States of America., Vogelzang NJ; US Oncology, United States of America., Perlmutter J; Gemini Group, Ann Arbor, MI, United States of America., Gorman M; Silver Spring, MD, United States of America., Manica B; Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, United States of America., Fox L; Yale Cancer Center, Yale University, New Haven, CT, United States of America., Schork N; Translational Genomics Research Institute, Phoenix, AZ, United States of America., Zelterman D; Yale Cancer Center, Yale University, New Haven, CT, United States of America., DeVeaux M; Yale Cancer Center, Yale University, New Haven, CT, United States of America.; Regeneron Pharmaceuticals, Tarrytown, NY, United States of America., Joseph RW; Mayo Clinic, Jacksonville, FL, United States of America., Cowey CL; Charles A. Sammons Cancer Center/Baylor University Medical Center, Dallas, TX, United States of America., Trent JM; Translational Genomics Research Institute, Phoenix, AZ, United States of America.
Source: PloS one [PLoS One] 2021 Apr 07; Vol. 16 (4), pp. e0248097. Date of Electronic Publication: 2021 Apr 07 (Print Publication: 2021).
Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1932-6203
DOI:10.1371/journal.pone.0248097